Frederick W. Driscoll

2016 - Flexion Therapeutics

In 2016, Frederick W. Driscoll earned a total compensation of $2.2M as Chief Financial Officer at Flexion Therapeutics, a 59% increase compared to previous year.

Compensation breakdown

Bonus$154,000
Option Awards$1,656,000
Salary$350,000
Other$22,538
Total$2,182,538

Driscoll received $1.7M in option awards, accounting for 76% of the total pay in 2016.

Driscoll also received $154K in bonus, $350K in salary and $22.5K in other compensation.

Rankings

In 2016, Frederick W. Driscoll's compensation ranked 4,493rd out of 14,075 executives tracked by ExecPay. In other words, Driscoll earned more than 68.1% of executives.

ClassificationRankingPercentile
All
4,493
out of 14,075
68th
Division
Manufacturing
1,588
out of 5,489
71st
Major group
Chemicals And Allied Products
486
out of 1,895
74th
Industry group
Drugs
357
out of 1,538
77th
Industry
Pharmaceutical Preparations
280
out of 1,176
76th
Source: SEC filing on April 28, 2017.

Driscoll's colleagues

We found two more compensation records of executives who worked with Frederick W. Driscoll at Flexion Therapeutics in 2016.

2016

Michael Clayman

Flexion Therapeutics

Chief Executive Officer

2016

Neil Bodick

Flexion Therapeutics

Chief Medical Officer

In-depth

You may also like